Clinicopathological Characteristics and Outcomes of Male Patients with Resected Distant Metastasis-Free Breast Cancer in A Single Center
Objective To investigate the clinicopathological features, treatment strategies and outcomes of male patients with resected distant metastasis-free breast cancer. Methods We retrospectively analyzed clinicopathological characteristics, clinical diagnosis, treatments and outcomes of 152 adult male patients with resected distant metastasis-free breast cancer. Results The median age was 58 years. Among 152 patients, the initial symptom of 142 cases was palpable lump and 4 cases were ductal carcinoma in situ. Among 148 cases of invasive carcinoma, 128 cases were invasive ductal carcinoma, 139 cases were estrogen receptor-positive and 11 cases were human epidermal growth factor receptor 2-positive. A total of 149 cases received mastectomy and 3 cases received breast conservation. Sentinel lymph node biopsy was performed on 19 patients, 4 cases were positive and 15 cases were negative, while 8 patients underwent axillary lymph node dissection. The median follow-up time was 42.7 (2-179.5) months. The 5-year overall survival rate and disease-free survival rate were 82.4% and 69.9%, respectively. Conclusion Lymph node status (N) is significantly associated with the disease-free survival and overall survival of male patients with resected distant metastasis-free breast cancer and it's an important prognostic factor..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Zhongliu Fangzhi Yanjiu - 47(2020), 2, Seite 97-101 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
MO Wenju [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Breast cancer |
|---|
| doi: |
10.3971/j.issn.1000-8578.2020.19.0946 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ075860678 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ075860678 | ||
| 003 | DE-627 | ||
| 005 | 20230309140046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2020 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3971/j.issn.1000-8578.2020.19.0946 |2 doi | |
| 035 | |a (DE-627)DOAJ075860678 | ||
| 035 | |a (DE-599)DOAJ0f19671e505a4dc8b9ba285e83bb5618 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 050 | 0 | |a RC254-282 | |
| 100 | 0 | |a MO Wenju |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinicopathological Characteristics and Outcomes of Male Patients with Resected Distant Metastasis-Free Breast Cancer in A Single Center |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective To investigate the clinicopathological features, treatment strategies and outcomes of male patients with resected distant metastasis-free breast cancer. Methods We retrospectively analyzed clinicopathological characteristics, clinical diagnosis, treatments and outcomes of 152 adult male patients with resected distant metastasis-free breast cancer. Results The median age was 58 years. Among 152 patients, the initial symptom of 142 cases was palpable lump and 4 cases were ductal carcinoma in situ. Among 148 cases of invasive carcinoma, 128 cases were invasive ductal carcinoma, 139 cases were estrogen receptor-positive and 11 cases were human epidermal growth factor receptor 2-positive. A total of 149 cases received mastectomy and 3 cases received breast conservation. Sentinel lymph node biopsy was performed on 19 patients, 4 cases were positive and 15 cases were negative, while 8 patients underwent axillary lymph node dissection. The median follow-up time was 42.7 (2-179.5) months. The 5-year overall survival rate and disease-free survival rate were 82.4% and 69.9%, respectively. Conclusion Lymph node status (N) is significantly associated with the disease-free survival and overall survival of male patients with resected distant metastasis-free breast cancer and it's an important prognostic factor. | ||
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a therapy | |
| 650 | 4 | |a prognosis | |
| 653 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
| 700 | 0 | |a DING Xiaowen |e verfasserin |4 aut | |
| 700 | 0 | |a GUO Zhenying |e verfasserin |4 aut | |
| 700 | 0 | |a ZHAO Shuai |e verfasserin |4 aut | |
| 700 | 0 | |a DING Yuqin |e verfasserin |4 aut | |
| 700 | 0 | |a CHEN Yiding |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Zhongliu Fangzhi Yanjiu |d Magazine House of Cancer Research on Prevention and Treatment, 2019 |g 47(2020), 2, Seite 97-101 |w (DE-627)DOAJ000006629 |x 10008578 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2020 |g number:2 |g pages:97-101 |
| 856 | 4 | 0 | |u https://doi.org/10.3971/j.issn.1000-8578.2020.19.0946 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/0f19671e505a4dc8b9ba285e83bb5618 |z kostenfrei |
| 856 | 4 | 0 | |u http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.0946.htm |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1000-8578 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1000-8578 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2020 |e 2 |h 97-101 | ||